<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/86BA0D2C-1895-41C5-B18C-092178DFFB3E"><gtr:id>86BA0D2C-1895-41C5-B18C-092178DFFB3E</gtr:id><gtr:name>National Institute for Health Research</gtr:name><gtr:address><gtr:line1>NIHR Clinical Research Network CC</gtr:line1><gtr:line2>Fairbairn House</gtr:line2><gtr:line3>71-75 Clarendon Road</gtr:line3><gtr:postCode>LS2 9PH</gtr:postCode><gtr:region>Yorkshire and the Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C26EC5DC-44D6-4728-8540-416E1CC7A2CB"><gtr:id>C26EC5DC-44D6-4728-8540-416E1CC7A2CB</gtr:id><gtr:name>University of Lisbon</gtr:name><gtr:address><gtr:line1>Campo Grande</gtr:line1><gtr:line2>Edificio C5</gtr:line2><gtr:line3>1749-016</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/941C2E74-C576-49DA-9987-CE40EF8A611D"><gtr:id>941C2E74-C576-49DA-9987-CE40EF8A611D</gtr:id><gtr:name>Pfizer</gtr:name><gtr:address><gtr:line1>235 East 42nd Street</gtr:line1><gtr:postCode>10017</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1A7923D7-9B3D-4944-8DC6-0C9F65AC96A4"><gtr:id>1A7923D7-9B3D-4944-8DC6-0C9F65AC96A4</gtr:id><gtr:name>La Jolla Pharmaceutical Company</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5D157790-D5A2-44E4-BCC3-24A8FDF74625"><gtr:id>5D157790-D5A2-44E4-BCC3-24A8FDF74625</gtr:id><gtr:name>Kymab</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/86BA0D2C-1895-41C5-B18C-092178DFFB3E"><gtr:id>86BA0D2C-1895-41C5-B18C-092178DFFB3E</gtr:id><gtr:name>National Institute for Health Research</gtr:name><gtr:address><gtr:line1>NIHR Clinical Research Network CC</gtr:line1><gtr:line2>Fairbairn House</gtr:line2><gtr:line3>71-75 Clarendon Road</gtr:line3><gtr:postCode>LS2 9PH</gtr:postCode><gtr:region>Yorkshire and the Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C26EC5DC-44D6-4728-8540-416E1CC7A2CB"><gtr:id>C26EC5DC-44D6-4728-8540-416E1CC7A2CB</gtr:id><gtr:name>University of Lisbon</gtr:name><gtr:address><gtr:line1>Campo Grande</gtr:line1><gtr:line2>Edificio C5</gtr:line2><gtr:line3>1749-016</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/941C2E74-C576-49DA-9987-CE40EF8A611D"><gtr:id>941C2E74-C576-49DA-9987-CE40EF8A611D</gtr:id><gtr:name>Pfizer</gtr:name><gtr:address><gtr:line1>235 East 42nd Street</gtr:line1><gtr:postCode>10017</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1A7923D7-9B3D-4944-8DC6-0C9F65AC96A4"><gtr:id>1A7923D7-9B3D-4944-8DC6-0C9F65AC96A4</gtr:id><gtr:name>La Jolla Pharmaceutical Company</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5D157790-D5A2-44E4-BCC3-24A8FDF74625"><gtr:id>5D157790-D5A2-44E4-BCC3-24A8FDF74625</gtr:id><gtr:name>Kymab</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/10560645-34E8-4617-A3C3-4C40175F363E"><gtr:id>10560645-34E8-4617-A3C3-4C40175F363E</gtr:id><gtr:firstName>Hal</gtr:firstName><gtr:surname>Drakesmith</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UU_12010%2F10"><gtr:id>76BED708-F853-464F-B75F-AC52512AB475</gtr:id><gtr:title>Hepcidin, iron and BMPs in immunity, infection and nutrition</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UU_12010/10</gtr:grantReference><gtr:abstractText>Iron is crucial for health ? we need it for our red blood cells and immune system to function. However, iron is equally vital for the organisms that infect us; iron availability to microbes can determine the outcome of infection. This has been known for decades, but recently a small peptide called hepcidin has been identified as the key regulator of human iron transport. Hepcidin is at least as important for iron as insulin is for glucose. We are studying how hepcidin behaves in various infections including malaria, tuberculosis and HIV-1, how hepcidin and the immune system interact, and testing whether new therapies can be based around measurement and manipulation of hepcidin.
Most infections increase hepcidin levels, but hepatitis C virus instead lowers hepcidin. We found HCV deactivates the cellular components that normally stimulate synthesis of hepcidin. We hypothesized that this behaviour might be advantageous for HCV if these hepcidin stimulators influenced replication of the virus. This seems to be the case, as we found that boosting the activity of the hepcidin stimulators prevented growth of HCV, due to unexpected antiviral properties that resemble the well-known functions of interferon. Understanding and exploiting this antiviral mechanism may lead to new types of antiviral therapy.</gtr:abstractText><gtr:technicalSummary>Hepcidin is the hormone that governs iron homeostasis ? it is equivalent in importance top the role of insulin in glucose balance. Iron is the most important nutrient in host / pathogen interactions; iron affects the outcome of infection, and infections can also lead to the anaemia of chronic inflammation. We aim to understand the role of hepcidin in major infectious diseases including malaria, tuberculosis, HIV-1, and candidiasis. We wish to understand how hepcidin is influenced by, and influences different types of adaptive immune responses, cellular immune function and vaccine efficacy. We will also test how manipulating hepcidin expression and activity can be used as a way of modulating infection and inflammation.
Iron deficiency and anaemia are major global health problem, but iron supplementation to anaemic individuals with high hepcidin is both useless and dangerous. Hepcidin is the major determinant of iron absorption in African children with varied types of anaemias. This means that hepcidin could be a useful diagnostic guide to improve safety and efficacy of iron supplementation, and we have studies planned to test this concept. 
Generally chronic infection / inflammation leads to persistently raised hepcidin levels and predisposes to anaemia, but the exception is chronic Hepatitis C virus (HCV), which causes low hepcidin and hepatic iron accumulation. We investigated the molecular basis of this phenomenon and found HCV interferes with the bone morphogenetic protein (BMP) signaling network that underpins homeostatic control of hepcidin transcription. Stimulating the BMP pathway restores hepcidin levels, but surprisingly also suppresses HCV replication and renders cells more sensitive to interferon. We now wish to understand how BMP signaling intersects with viral sensing and IFN function, and whether BMPs can be used to inhibit other viruses.
Developing our studies on BMP signaling and its antiviral properties has potential benefit for understanding innate immune defences against viruses, and using this knowledge to predict how some patients will respond to infection and current treatment regimens. We are developing new small molecule BMP agonists with antiviral activity that could improve treatment efficacy. The advantage of this approach is that by boosting a hitherto unappreciated arm of innate immune defence we may generate broadly acting antivirals that synergise with current therapies against a variety of viruses.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1220000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs><gtr:artisticAndCreativeProductOutput><gtr:description>interview in which the work of my lab is described</gtr:description><gtr:id>1A40CC66-A481-4F92-853F-4013EABE1FF5</gtr:id><gtr:impact>students and post-docs joking my lab have said they viewed the podcast and this did not discourage them too much...</gtr:impact><gtr:outcomeId>56d586e751f342.35983455</gtr:outcomeId><gtr:title>Podcast describing my research</gtr:title><gtr:type>Film/Video/Animation</gtr:type><gtr:url>http://www.ndm.ox.ac.uk/hal-drakesmith-iron-and-infection</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput><gtr:artisticAndCreativeProductOutput><gtr:description>I wrote the script / designed the story for a series of videos explaining the activities of the Weatherall Institute of Molecular Medicine</gtr:description><gtr:id>DD7FC664-A5EA-46A2-91BA-3C180D4999EE</gtr:id><gtr:impact>multiple viewings; follow-through to investigate the WIMM website

prospective students and post-docs report viewing the videos</gtr:impact><gtr:outcomeId>56d5866f547515.28997192</gtr:outcomeId><gtr:title>Video describing WIMM activities</gtr:title><gtr:type>Film/Video/Animation</gtr:type><gtr:url>http://www.imm.ox.ac.uk/engage</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput></gtr:artisticAndCreativeProductOutputs><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Kymab</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>new treatments for anaemia of inflammation</gtr:description><gtr:id>CEDF3A0B-7787-4259-B5E1-E02CF933A1D7</gtr:id><gtr:impact>none yet besides the funding</gtr:impact><gtr:outcomeId>56d5778dd7e952.75951332-1</gtr:outcomeId><gtr:partnerContribution>generation of reagents</gtr:partnerContribution><gtr:piContribution>testing reagents for efficacy in defined experimental systems</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC International Nutrition Group</gtr:department><gtr:description>investigating iron in infectious diseases</gtr:description><gtr:id>5F37F964-326B-4B29-BAF4-11522AFB5204</gtr:id><gtr:impact>18552864</gtr:impact><gtr:outcomeId>77B76455279-1</gtr:outcomeId><gtr:partnerContribution>more opportunity to access patient samples to measure desired parameters, in order to assess how disease outcome correlates with iron status.</gtr:partnerContribution><gtr:piContribution>measured hepcidin in sera of infected patients</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Lisbon</gtr:collaboratingOrganisation><gtr:country>Portugal, Portuguese Republic</gtr:country><gtr:department>Institute for Molecular Medicine</gtr:department><gtr:description>Malaria and hepcidin</gtr:description><gtr:id>DD722C3A-69D1-4CE4-8C08-F85584286E3C</gtr:id><gtr:impact>Host-mediated regulation of superinfection in malaria.
Portugal S, Carret C, Recker M, Armitage AE, Gon&amp;ccedil;alves LA, Epiphanio S, Sullivan D, Roy C, Newbold CI, Drakesmith H, Mota MM.
Nat Med. 2011 Jun;17(6):732-7. Epub 2011 May 15.</gtr:impact><gtr:outcomeId>JUg69kpcw1t-1</gtr:outcomeId><gtr:partnerContribution>co-work on a publication</gtr:partnerContribution><gtr:piContribution>role of hepcidin in malarial pathogenesis especially superinfection</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Health Research</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>NIHR Biomedical Research Centre</gtr:department><gtr:description>evaluating hepcidin as a diagnostic tool in the OUH Trust</gtr:description><gtr:id>158A0801-1FB1-4848-A049-86B264C60F85</gtr:id><gtr:impact>an ACF post for a clinician, continued funding from BRC for a technician in my lab

multidisciplinary: haematology, immunology, obs + gynae, peri-operative care, intensive care units</gtr:impact><gtr:outcomeId>56d575c5bbf797.27952537-1</gtr:outcomeId><gtr:partnerContribution>clinical expertise, access to patient groups, ethical permissions</gtr:partnerContribution><gtr:piContribution>We measure hepcidin and design prospective investigations in different patient cohorts (per-operative anaemia, antenatal, intensive care) to test how hepcidin can aid in diagnosis of iron deficiency versus anaemia of inflammation and guide decisions to provide iron therapy; and whether oral or i/v iron should be given.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>La Jolla Pharmaceutical Company</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Do hepcidin and haem enhance the anti-malarial efficacy of artemsinin?</gtr:description><gtr:id>24EFD0D7-9BB7-432E-B1E7-A77EF2FE6141</gtr:id><gtr:impact>none yet</gtr:impact><gtr:outcomeId>58c7ce7a552c44.67868189-1</gtr:outcomeId><gtr:partnerContribution>funding and reagents</gtr:partnerContribution><gtr:piContribution>We are testing whether hepcidin and haem enhance the anti-malarial efficacy of artemsinin</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Hepcidin and tuberculosis</gtr:description><gtr:id>BCF3560D-261F-45C9-A413-AAAF83ECFEC3</gtr:id><gtr:impact>contributed to the development of the HIGH Consortium (see elsewhere in my input).</gtr:impact><gtr:outcomeId>JLy3GSUmYNL-1</gtr:outcomeId><gtr:partnerContribution>co-supervise student, host experiments</gtr:partnerContribution><gtr:piContribution>co-supervise a DPhil student</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Inc</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>new treatments for anaemia of inflammation and for iron overload of thalassaemia</gtr:description><gtr:id>97218C8E-B73E-4589-B884-CBEFA6BA208A</gtr:id><gtr:impact>employment for two post-docs for three years

mutidisciplinary: immunology, haematology, protein biology</gtr:impact><gtr:outcomeId>56d577102ee340.52169590-1</gtr:outcomeId><gtr:partnerContribution>generation of some of the reagents, some of the screening resources</gtr:partnerContribution><gtr:piContribution>Business plan to work with Pfizer to develop and test new treatments for anaemia of inflammation and for iron overload of thalassaemia</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Weatherall Institute of Molecular Medicine (WIMM)</gtr:department><gtr:description>measuring hepcidin in acute viral infections</gtr:description><gtr:id>D651BDBC-2996-42E4-9193-0B0D1858633E</gtr:id><gtr:impact>publications in preparation</gtr:impact><gtr:outcomeId>fKxMHkMmuWv-1</gtr:outcomeId><gtr:partnerContribution>they provided the samples and helped do the measurements</gtr:partnerContribution><gtr:piContribution>we measured hepcidin in samples from individuals with acute viral infections and correlated these with acute phase proteins and cytokines</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Chair of WIMM Public Engagement Committee</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>66706D97-22F5-4671-B06D-8542909B28F2</gtr:id><gtr:impact>WIMM Newsletter; WIMM Video; WIMM display at MRC 100 event; launch of a WIMM Public Engagement award

WIMM Public Engagement database; greater awareness of WIMM members as to the reach and breadth of WIMM activities; aim to increase local, national and international profile of the WIMM</gtr:impact><gtr:outcomeId>LXuzihHkj4c</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Centenary Event in Oxford</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3F248BA4-3536-4CAB-B64E-599BFE6B2933</gtr:id><gtr:impact>Co-designed posters and displays for the MRC HIU and MRC MHU displays at MRC 100 event. Attended the event; the displays attracted many hundreds of people.

Surge of interest and subsequent engagement in public engagement from WIMM members who took part.</gtr:impact><gtr:outcomeId>UbcU5mX73gj</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit of 50 students plus four teachers from Utrecht College to the WIMM, Oxford (my institute)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0EBFE468-966B-4365-B592-0E6095A99C9C</gtr:id><gtr:impact>50 students from Utrecht College (16-17 year old, studying biomedicine) came for a specially designed Open Day at the WIMM. I co-hosted the event, gave two lectures, organised tours of the labs, catering, etc etc.
Extremely good feedback was received via evaluation forms describing the interest of the students and in many cases that it increased their commitment to want to study medicine / bioscience.</gtr:impact><gtr:outcomeId>56d580b249dde2.02485527</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>newsletter for the WIMM</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>04427416-7761-4566-A556-A9FE97FD4868</gtr:id><gtr:impact>I write newsletters for the WIMM that contain information on new arrivals to the institute, grants and papers from WIMM members, important activities related to the WIMM. It is for internal circulation to engage all WIMM members with happenings in the Institute.

a lot of feedback from WIMM members on how useful it is</gtr:impact><gtr:outcomeId>Af71NYDV88X</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit (Oxford)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>3244A1DD-575A-42F4-A6E1-31FB7B65DF4A</gtr:id><gtr:impact>I described the importance of blood to year 1 school children at a local primary school. I contrasted human blood and lobster blood. The school reported enormous enthusiasm and the children still talk about the visit many weeks later (apparently).</gtr:impact><gtr:outcomeId>58c7d2512ac0f8.90867780</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>WIMM video</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0E140A50-8DDF-48CC-9249-D66A7C051D75</gtr:id><gtr:impact>I co-designed and wrote the script for a WIMM video, funded by the MRC, describing the history and activities of the WIMM. Three versions were made - one for a scientific audience, one for a lay audience, and a shorter version suitable for any audience.

&amp;gt;700 viewings of the video, which is posted on the WIMM webpage, on the Oxford University youtube channel, the MRC youtube website, and promoted via Twitter</gtr:impact><gtr:outcomeId>fTmZDGx9k8g</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.youtube.com/watch?v=y_8qtXM53IA&amp;hd=1</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>La Jolla Pharmaceutical Company research grant</gtr:description><gtr:fundingOrg>La Jolla Pharmaceutical Company</gtr:fundingOrg><gtr:id>7A4CD77E-1543-47BC-B51A-3A49329FA785</gtr:id><gtr:outcomeId>58c7d15ba48f84.24149385</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1800000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Gates Foundation Global Health Grant</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1055865</gtr:fundingRef><gtr:id>EA0740D4-AA31-4648-9FE3-28040D86C48A</gtr:id><gtr:outcomeId>Uwa8uGtmP2C</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Radcliffe Department of Medicine</gtr:department><gtr:description>Exploring how the FAM132B gene links iron homeostasis, energy metabolism and erythropoiesis</gtr:description><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>CC72B1FE-E8F4-422E-88B8-BC370D5BA8A0</gtr:id><gtr:outcomeId>58c7d06423fdf4.23728112</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>900000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Pfizer-Sponsored Rare Disease Consortium Award</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>Pfizer Inc</gtr:fundingOrg><gtr:id>0700AB66-80D7-4324-972F-CD371A1BFBA6</gtr:id><gtr:outcomeId>56d57a1c3f1bb8.91107556</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>70000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Kymab research collaboration</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>Kymab</gtr:fundingOrg><gtr:id>BCED250B-2D81-43F5-8926-0013987952BD</gtr:id><gtr:outcomeId>56d57a69c17c23.96282795</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>24437</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Radcliffe Department of Medicine</gtr:department><gtr:description>Regulation of Iron Redox Metabolism by Tetrahydrobiopterin</gtr:description><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>4EF8E61B-358C-431E-92D8-3365BC4A0D4B</gtr:id><gtr:outcomeId>58c7d0f95555b4.13111248</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>292052</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Doctoral Training Fellowship</gtr:department><gtr:description>Wellcome Trust clinician PhD scheme</gtr:description><gtr:end>2017-01-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:fundingRef>102341/Z/13/Z</gtr:fundingRef><gtr:id>0BB1375F-D52E-48DA-81A7-6652A9FC446E</gtr:id><gtr:outcomeId>56d5a2c320f711.59299365</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>using hepcidin as a biomarker to 1) diagnose iron deficiency; 2) distinguish iron deficiency anaemia from anaemia of inflammation; 3) guide iron supplementation
assessed potential efficacy of hepcidin as a diagnostic tool in retrospective analysis of &amp;gt;5000 children and patients in Africa, Sri Lanka and Oxford
ongoing clinical trial in The Gambia to test whether hepcidin can guide iron supplementation in children and pregnant women
initiating similar studies in Oxford targeted at pregnant women, patients in and leaving ICU, and pre-operative care</gtr:description><gtr:id>48734E5F-54CF-438D-9249-F38F4D295443</gtr:id><gtr:impact>interest from Pfizer to develop therapeutics based around manipulating hepcidin expression, leading to a new funding stream.</gtr:impact><gtr:outcomeId>56d585aa849b22.56346529</gtr:outcomeId><gtr:stage>Refinement.  Clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>hepcidin assay</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2015</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>we have modified and optimised a commercially available Elisa kit to measure hepcidin, the master regulator of iron metabolism, in human serum / plasma</gtr:description><gtr:id>10413A0D-1935-4A5F-B9F2-3E686343FEAE</gtr:id><gtr:impact>Blood. 2012 Feb 23;119(8):1922-8. Epub 2012 Jan 6.
Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children.
Prentice AM, Doherty CP, Abrams SA, Cox SE, Atkinson SH, Verhoef H, Armitage AE, Drakesmith H.
and other publications Atkinson et al Blood 2014; Pasricha et al Sci Transl Med 2014; Armitage et al PNAS 2014

Gates Foundation Global Health Grant to study use of hepcidin to guide iron supplementation</gtr:impact><gtr:outcomeId>g87NSp838MM</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>serum hepcidin measurement</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>88965371-79DC-4230-94DE-79150ED6F857</gtr:id><gtr:title>Malaria and Age Variably but Critically Control Hepcidin Throughout Childhood in Kenya.</gtr:title><gtr:parentPublicationTitle>EBioMedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc5d54fd557c51a327ad1d34b5322226"><gtr:id>bc5d54fd557c51a327ad1d34b5322226</gtr:id><gtr:otherNames>Atkinson SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2352-3964</gtr:issn><gtr:outcomeId>56d571b2557fd1.34240932</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4EBFA5F-A692-4A31-A6C4-A41152A75727</gtr:id><gtr:title>Short-Term versus Long-Term Blood Storage.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5048a6bda99f73fef470ed75036df6ef"><gtr:id>5048a6bda99f73fef470ed75036df6ef</gtr:id><gtr:otherNames>Ryan JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>5aa794cf236394.35226533</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C08AB701-67D5-4354-9A9B-1CED0157A7D2</gtr:id><gtr:title>Intravenous iron and vertical HIV transmission: any connection?</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0face8aeeccf25b3c835e913f610d8f3"><gtr:id>0face8aeeccf25b3c835e913f610d8f3</gtr:id><gtr:otherNames>Thompson F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>5458e0ccc171d3.92891642</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98B1D4BC-75B9-47E4-A38B-8758B111A397</gtr:id><gtr:title>Serum Hepcidin Concentrations Decline during Pregnancy and May Identify Iron Deficiency: Analysis of a Longitudinal Pregnancy Cohort in The Gambia.</gtr:title><gtr:parentPublicationTitle>The Journal of nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99dd77bcfcf9e0088df4f5b9e86309cf"><gtr:id>99dd77bcfcf9e0088df4f5b9e86309cf</gtr:id><gtr:otherNames>Bah A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-3166</gtr:issn><gtr:outcomeId>5aa794ce5f6848.16169701</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>513F84E0-900F-41EF-B614-0015F22047CC</gtr:id><gtr:title>Control of iron deficiency anemia in low- and middle-income countries.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/393f975ed0d279c1e271776d221d70b0"><gtr:id>393f975ed0d279c1e271776d221d70b0</gtr:id><gtr:otherNames>Pasricha SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_14899_29_23355536</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C90A0BD-E116-40CE-A270-2337AC89ED47</gtr:id><gtr:title>The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8575b6f276f22dfafd204c0c78b3ff00"><gtr:id>8575b6f276f22dfafd204c0c78b3ff00</gtr:id><gtr:otherNames>Tanner R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58c5b3bbc0b6d7.04536809</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B0C07A1-2573-4C8B-A951-1A5860602F37</gtr:id><gtr:title>Regulation of Hepcidin by Erythropoiesis: The Story So Far.</gtr:title><gtr:parentPublicationTitle>Annual review of nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/393f975ed0d279c1e271776d221d70b0"><gtr:id>393f975ed0d279c1e271776d221d70b0</gtr:id><gtr:otherNames>Pasricha SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0199-9885</gtr:issn><gtr:outcomeId>58c5b3bc887a13.83939913</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9974C30F-E1DC-443E-9696-7BACFA83CF7B</gtr:id><gtr:title>Hepcidin is regulated by promoter-associated histone acetylation and HDAC3.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/393f975ed0d279c1e271776d221d70b0"><gtr:id>393f975ed0d279c1e271776d221d70b0</gtr:id><gtr:otherNames>Pasricha SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5aa7940f3a4462.72383857</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>804358FE-0A32-428B-8A25-D96033AEF506</gtr:id><gtr:title>Serum hepcidin potentially identifies iron deficiency in survivors of critical illness at the time of hospital discharge.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35233ed9adaf19841a3034fd01bb9467"><gtr:id>35233ed9adaf19841a3034fd01bb9467</gtr:id><gtr:otherNames>Shah A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>5aa7940e90f2a2.27654992</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>888B8547-A2D7-43E9-8660-B189F05B28E1</gtr:id><gtr:title>Elevated Hepcidin Is Part of a Complex Relation That Links Mortality with Iron Homeostasis and Anemia in Men and Women with HIV Infection.</gtr:title><gtr:parentPublicationTitle>The Journal of nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/109444a10d09e9ed58baf403ba7c3ac8"><gtr:id>109444a10d09e9ed58baf403ba7c3ac8</gtr:id><gtr:otherNames>Minchella PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3166</gtr:issn><gtr:outcomeId>56d571b36a3cf7.06914865</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C99B6BE-C844-4405-BF3E-CE50EB0BB160</gtr:id><gtr:title>Induced Disruption of the Iron-Regulatory Hormone Hepcidin Inhibits Acute Inflammatory Hypoferraemia.</gtr:title><gtr:parentPublicationTitle>Journal of innate immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13c9270163e5a00e5919e9e956c231ab"><gtr:id>13c9270163e5a00e5919e9e956c231ab</gtr:id><gtr:otherNames>Armitage AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1662-811X</gtr:issn><gtr:outcomeId>58c5b3bc159e24.62377002</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38E45DFB-6F58-48C5-B43F-C72D49CF5E41</gtr:id><gtr:title>Elevated hepcidin at HIV diagnosis is associated with incident tuberculosis in a retrospective cohort study.</gtr:title><gtr:parentPublicationTitle>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/109444a10d09e9ed58baf403ba7c3ac8"><gtr:id>109444a10d09e9ed58baf403ba7c3ac8</gtr:id><gtr:otherNames>Minchella PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1027-3719</gtr:issn><gtr:outcomeId>5458e0cc5dcdb7.18830059</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF701435-A9F9-47B3-BD5C-8351D6099C3E</gtr:id><gtr:title>Toward Worldwide Hepcidin Assay Harmonization: Identification of a Commutable Secondary Reference Material.</gtr:title><gtr:parentPublicationTitle>Clinical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2f06ce0e28ae272c8da1bd216c212da"><gtr:id>d2f06ce0e28ae272c8da1bd216c212da</gtr:id><gtr:otherNames>van der Vorm LN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0009-9147</gtr:issn><gtr:outcomeId>58c5b3bc51e495.86032602</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FCC55AA8-B65A-4FB4-8E5F-D66D7F98DFE7</gtr:id><gtr:title>From one Nobel Prize (P. Ehrlich) to another (Tu Youyou): 100 years of chemotherapy of infectious diseases.</gtr:title><gtr:parentPublicationTitle>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c21a1d6fad09c59ccbad113d3cba79c"><gtr:id>1c21a1d6fad09c59ccbad113d3cba79c</gtr:id><gtr:otherNames>Cabantchik ZI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1198-743X</gtr:issn><gtr:outcomeId>56d571b23042f8.10451148</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46B05BE0-3A1E-41EE-86F1-4E46159EEEE0</gtr:id><gtr:title>Hepatic iron is the major determinant of serum ferritin in NAFLD patients.</gtr:title><gtr:parentPublicationTitle>Liver international : official journal of the International Association for the Study of the Liver</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5048a6bda99f73fef470ed75036df6ef"><gtr:id>5048a6bda99f73fef470ed75036df6ef</gtr:id><gtr:otherNames>Ryan JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1478-3223</gtr:issn><gtr:outcomeId>5aa794ce1ac1d4.74788652</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98A8F181-15AE-4099-9F0E-2A89EB494118</gtr:id><gtr:title>Genetics. The battle for iron.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13c9270163e5a00e5919e9e956c231ab"><gtr:id>13c9270163e5a00e5919e9e956c231ab</gtr:id><gtr:otherNames>Armitage AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>56d571b3f1be67.46458034</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>339327DA-0DC4-4B6E-97D6-02FA08007C98</gtr:id><gtr:title>Iron, anemia and hepcidin in malaria.</gtr:title><gtr:parentPublicationTitle>Frontiers in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f74b171beed8655598b3801c6e65ac4"><gtr:id>8f74b171beed8655598b3801c6e65ac4</gtr:id><gtr:otherNames>Spottiswoode N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1663-9812</gtr:issn><gtr:outcomeId>5458e0cc2e8424.10160888</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A10AAC37-64E5-4391-979F-E81F89351D31</gtr:id><gtr:title>Cord Blood Hepcidin: Cross-Sectional Correlates and Associations with Anemia, Malaria, and Mortality in a Tanzanian Birth Cohort Study.</gtr:title><gtr:parentPublicationTitle>The American journal of tropical medicine and hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40fce04c808ecba0ff3bb14f2715b780"><gtr:id>40fce04c808ecba0ff3bb14f2715b780</gtr:id><gtr:otherNames>Brickley EB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9637</gtr:issn><gtr:outcomeId>58c5b3bc343ad3.40821650</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F0BEDB1-6C8F-4291-8B2E-4F26D78E37DD</gtr:id><gtr:title>Improving iron supplements: cooking with GOS.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69897495557bb9049b1db1d20db3e201"><gtr:id>69897495557bb9049b1db1d20db3e201</gtr:id><gtr:otherNames>Drakesmith H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>5aa7940f8fe5a1.97572743</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FDE5F7C-D4A9-461E-BB1F-99CDCBD42A61</gtr:id><gtr:title>Combinatorial effects of malaria season, iron deficiency, and inflammation determine plasma hepcidin concentration in African children.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc5d54fd557c51a327ad1d34b5322226"><gtr:id>bc5d54fd557c51a327ad1d34b5322226</gtr:id><gtr:otherNames>Atkinson SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>doi_14899__10_533000</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>067BC099-4487-4F4B-9082-CB4F9BDB11FE</gtr:id><gtr:title>Ironing out Ferroportin.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69897495557bb9049b1db1d20db3e201"><gtr:id>69897495557bb9049b1db1d20db3e201</gtr:id><gtr:otherNames>Drakesmith H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>56d571b2a30c58.02167935</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99F58290-4593-4443-9256-F6EB80C380BF</gtr:id><gtr:title>A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/440507e60a711136d84cefc5af4f6758"><gtr:id>440507e60a711136d84cefc5af4f6758</gtr:id><gtr:otherNames>Nickol AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>56d571b337fe62.08404430</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE61B4ED-E241-479A-A53C-4FE23723F81B</gtr:id><gtr:title>Expression of the iron hormone hepcidin distinguishes different types of anemia in African children.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/393f975ed0d279c1e271776d221d70b0"><gtr:id>393f975ed0d279c1e271776d221d70b0</gtr:id><gtr:otherNames>Pasricha SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>doi_14899_ed_3008249</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AB3F834-28BA-4502-B789-F89C2C5216F1</gtr:id><gtr:title>Hepcidin deficiency and iron deficiency do not alter tuberculosis susceptibility in a murine M.tb infection model.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/323643a98aa549bd657816ef5fe1d44e"><gtr:id>323643a98aa549bd657816ef5fe1d44e</gtr:id><gtr:otherNames>Harrington-Kandt R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5aa7940ec56c93.67287891</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E37B99DE-6C41-4D15-ABD8-92D0186DA23F</gtr:id><gtr:title>Hepcidin detects iron deficiency in Sri Lankan adolescents with a high burden of hemoglobinopathy: A diagnostic test accuracy study.</gtr:title><gtr:parentPublicationTitle>American journal of hematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc040afaff8b8a43566158217d4cb069"><gtr:id>dc040afaff8b8a43566158217d4cb069</gtr:id><gtr:otherNames>Wray K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0361-8609</gtr:issn><gtr:outcomeId>58c5b3bbeaaaa6.22194556</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A900A401-1410-4ABE-8D4D-49EAAB5E284D</gtr:id><gtr:title>Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13c9270163e5a00e5919e9e956c231ab"><gtr:id>13c9270163e5a00e5919e9e956c231ab</gtr:id><gtr:otherNames>Armitage AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5458e0cc9a2418.31231050</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D017E2A-BE96-480E-9C4A-B64CFB8464B6</gtr:id><gtr:title>Next-Generation Biomarkers for Iron Status.</gtr:title><gtr:parentPublicationTitle>Nestle Nutrition Institute workshop series</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69897495557bb9049b1db1d20db3e201"><gtr:id>69897495557bb9049b1db1d20db3e201</gtr:id><gtr:otherNames>Drakesmith H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1664-2147</gtr:issn><gtr:outcomeId>56d571b1cdd240.81897558</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81989C8E-B0F1-4F11-8595-2945C4D5D07C</gtr:id><gtr:title>Iron Deficiency Anemia: Problems in Diagnosis and Prevention at the Population Level.</gtr:title><gtr:parentPublicationTitle>Hematology/oncology clinics of North America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/393f975ed0d279c1e271776d221d70b0"><gtr:id>393f975ed0d279c1e271776d221d70b0</gtr:id><gtr:otherNames>Pasricha SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0889-8588</gtr:issn><gtr:outcomeId>58c5b3bca80b83.08878408</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87F30039-5C57-4319-A350-4D1D5B3E6082</gtr:id><gtr:title>Role of Activins in Hepcidin Regulation during Malaria.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f74b171beed8655598b3801c6e65ac4"><gtr:id>8f74b171beed8655598b3801c6e65ac4</gtr:id><gtr:otherNames>Spottiswoode N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>5aa7940f04c680.32218242</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FF994EA-8464-447D-8B2D-77A171EA4F28</gtr:id><gtr:title>Hepcidin is suppressed by erythropoiesis in hemoglobin E ?-thalassemia and ?-thalassemia trait.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e050bd6475c7c807ec5722cb9a2cc56"><gtr:id>7e050bd6475c7c807ec5722cb9a2cc56</gtr:id><gtr:otherNames>Jones E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>56d571b395eaf9.47271542</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7030D82C-36A5-4772-96BE-78D2B96D6D86</gtr:id><gtr:title>Rapidly Escalating Hepcidin and Associated Serum Iron Starvation Are Features of the Acute Response to Typhoid Infection in Humans.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbf202e1cd4288aceb44ec51fda97ce8"><gtr:id>cbf202e1cd4288aceb44ec51fda97ce8</gtr:id><gtr:otherNames>Darton TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>56d571b2ea1c76.79792720</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UU_12010/10</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>